Literature DB >> 17380888

[Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease].

K V Danilko, G F Korytina, L Z Akhmidishina, D G Ianbaeva, Sh Z Zagidullin, T V Victorova.   

Abstract

The purpose of this study was to investigate the possible roles of the cytokines genes in the development of chronic obstructive pulmonary disease (COPD). Polymorphisms in the genes encoding IL1B, IL1RN, TNFA, LTA, IL6, IL8 H IL10 were investigated in COPD patients (N = 319) and healthy individuals (N = 403) living in Ufa, the Republic of Bashkortostan. We observed that IL1RN*2/IL1RN*2 genotype of ILRN gene was associated with susceptibility for COPD (9.8% vs. 4.67%; chi(2)= 5.45, df= 1, P = 0.02; OR = 2.21). Analysis of the LTA gene polymorphic locus A252G showed that in patients with COPD, the frequency of the GG genotype was significantly higher than that in the control group (7.84% vs. 3.72%; chi(2) = 5.00, df= 1, P = 0.025). The increase of this genotype was significant in case of stage IV of COPD (11.18% vs. 4.79%; chi(2) = 3.075, df= 1, P = 0.07). Frequency of genotype combination TNFA-308 G/G and LTA252 A/A significantly decreased in COPD group (38.55% vs. 46.93% in control group; chi(2) = 8.82, df= 1, P = 0.0039). The frequency of GG genotype of the IL6 gene was higher in the patients with stage IV of COPD (43.75% vs. 31.54%, chi(2) = 4.14, P = 0.041). Our results indicate that the genotype frequency of the T(-511)C, T3953C of IL1B, G(-308)A of TNFA, G(-1 74)C of IL6, A(-251)C of IL8 and C(-627)A of ILl0 genes polymorphisms was similar in COPD and healthy control groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380888

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  7 in total

1.  Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells.

Authors:  Mark J Paul-Clark; Rosalinda Sorrentino; Lucy K Bailey; Shiranee Sriskandan; Jane A Mitchell
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

Review 2.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

3.  TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study.

Authors:  Elizabeth Córdoba-Lanús; Rebeca Baz-Dávila; Juan P de-Torres; María C Rodríguez-Pérez; Nicole Maca-Meyer; Nerea Varo; Chaxiraxi Medina-Coello; Armando Aguirre-Jaime; Ciro Casanova
Journal:  BMC Med Genet       Date:  2011-10-10       Impact factor: 2.103

Review 4.  Paraclinical findings in Iranian veterans exposed to sulfur mustard gas: A literature review.

Authors:  Seyed Mansour Razavi; Masoud Saghafinia; Payman Salamati
Journal:  Chin J Traumatol       Date:  2017-02-21

5.  TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning.

Authors:  Juan Manuel Reséndiz-Hernández; Enrique Ambrocio-Ortiz; Gloria Pérez-Rubio; Luis Alberto López-Flores; Edgar Abarca-Rojano; Gandhi Fernando Pavón-Romero; Fernando Flores-Trujillo; Rafael de Jesús Hernández-Zenteno; Ángel Camarena; Martha Pérez-Rodríguez; Ana María Salazar; Alejandra Ramírez-Venegas; Ramcés Falfán-Valencia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-16

6.  Differential expression of inflammatory responsive genes between chronic periodontitis and periodontally affected bronchiectasis patients.

Authors:  Abhaya Gupta; Neetu Singh; Anil Kumar; Umesh Pratap Verma; Ajay Kumar Verma; Hari Shyam; Nand Lal; Surya Kant; Ankur Kumari
Journal:  Mol Biol Res Commun       Date:  2020-12

7.  Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis.

Authors:  Alireza Shahriary; Yunes Panahi; Saeed Shirali; Hossein Rahmani
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.